Search - tctmd.com

Displaying 101 - 120 of 1480

Sort: Relevancy | Date

News Conference News ACC 2024

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

L.A. McKeown

April 08, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

News Conference News ACC 2024

EDTA Chelation No Help in Cutting CV Outcomes After MI in Diabetic Patients: TACT2

Shelley Wood

April 07, 2024

Podcast TCTMD Talking Points

The ORBITA-2 Trial

April 03, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

Shelley Wood

April 01, 2024

News Conference News ACC 2024

Icosapent Ethyl Lowers CV Risk Across Lp(a) Range: REDUCE-IT

Todd Neale

March 27, 2024

News Daily News

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Todd Neale

March 04, 2024

News Daily News

Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing

Yael L. Maxwell

March 01, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

CTO Diagnosed, Now What? European Experts Offer Advice on Revascularization

Caitlin E. Cox

February 09, 2024

News Daily News

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Michael O'Riordan

February 08, 2024

News Conference News

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

L.A. McKeown

February 02, 2024

Presentation CTO Plus 2024 Abstracts On-Demand 2024

Comparison of Coronary CT- Angiography and Functional Stress Testing in Patients with Stable Angina: A Systemic Review and Meta-Analysis

Presenter: Muhammad Adil Afzal

February 02, 2024

News Daily News

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Michael O'Riordan

January 30, 2024

News Features

A Sham-Controlled Trial of AF Ablation Is Feasible, but Is It Needed?

Todd Neale

January 25, 2024

News Daily News

Erectile Dysfunction Drugs Don’t Mix Well With Nitrates After MI, PCI

Todd Neale

January 16, 2024

News Daily News

COVID-Related Decline in Acute CV Hospitalizations Sustained Through 2021

Todd Neale

January 09, 2024

News Daily News

Exercise Testing in ANOCA Uncovers Microvascular Dysfunction

Caitlin E. Cox

January 08, 2024

Advertisement

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

EDTA Chelation No Help in Cutting CV Outcomes After MI in Diabetic Patients: TACT2

The ORBITA-2 Trial

April 2024 Dispatch for the CV Team

What’s Going to Be Hot at ACC 2024

Icosapent Ethyl Lowers CV Risk Across Lp(a) Range: REDUCE-IT

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

CTO Diagnosed, Now What? European Experts Offer Advice on Revascularization

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

Comparison of Coronary CT- Angiography and Functional Stress Testing in Patients with Stable Angina: A Systemic Review and Meta-Analysis

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

A Sham-Controlled Trial of AF Ablation Is Feasible, but Is It Needed?

Erectile Dysfunction Drugs Don’t Mix Well With Nitrates After MI, PCI

COVID-Related Decline in Acute CV Hospitalizations Sustained Through 2021

Exercise Testing in ANOCA Uncovers Microvascular Dysfunction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content